Position in AMGN
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$52,706,203
+$2,918,725 QoQ
Shares Held
145,549
+2.9% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#217
of 3,139 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 7%
Shared 0%
None 93%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MERCER GLOBAL ADVISORS INC /ADV holds $931,707,784 across 15 Drug Manufacturers - General names. AMGN ranks #5 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
931,576 | $236,592,356 | |
| 2 | LLY |
ELI LILLY & Co
|
189,731 | $227,569,072 | |
| 3 | ABBV |
AbbVie Inc.
|
543,313 | $136,719,283 | |
| 4 | MRK |
Merck & Co., Inc.
|
845,459 | $108,641,481 | |
| 5 | AMGN |
Amgen Inc
This page
|
145,549 | $52,706,203 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
309,147 | $39,057,631 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
636,124 | $36,653,464 | |
| 8 | PFE |
Pfizer Inc
|
1,165,477 | $28,064,686 |
All Filings in AMGN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52,706,203 | 145,549 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $49,787,478 | 141,502 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $47,249,489 | 144,357 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $34,196,431 | 121,178 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $32,245,125 | 115,487 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $37,521,835 | 120,436 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $30,374,203 | 116,537 | Shares | Sole | 2025-02-14 | |
| 2023-12-31 | $69,780,045 | 242,275 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $25,557,463 | 95,094 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $20,581,920 | 92,703 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $20,773,819 | 85,931 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $21,273,314 | 80,998 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $17,425,899 | 77,311 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $17,388,164 | 71,468 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $15,055,713 | 62,260 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $12,346,578 | 54,881 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $13,098,176 | 61,595 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $12,852,206 | 52,727 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $14,123,202 | 56,763 | Shares | Sole | 2021-08-10 | |
| 2020-12-31 | $10,960,746 | 47,672 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $11,680,176 | 45,956 | Shares | Sole | 2020-12-10 | |
| 2020-06-30 | $10,544,357 | 44,706 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $8,512,429 | 41,989 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||